ID   VIDO R2
AC   CVCL_RT37
SY   VIDO-R2; VIDOR2; Veterinary Infectious Disease Organization Retina-2
DR   Wikidata; Q54993167
RX   Patent=US6458586;
RX   PubMed=10516020;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); PTA-156.
CC   Transformant: NCBI_TaxID; 28285; Adenovirus 5 [Note=E1A/E1B].
CC   Derived from site: In situ; Fetal eye, retina; UBERON=UBERON_0003072.
OX   NCBI_TaxID=9913; ! Bos taurus (Bovine)
SX   Sex unspecified
AG   Fetus
CA   Transformed cell line
DT   Created: 05-03-18; Last updated: 05-10-23; Version: 7
//
RX   Patent=US6458586;
RA   Tikoo S.K., Babiuk L.A., Reddy P.S.;
RT   "Bovine cells expressing adenovirus essential functions for
RT   propagation of recombinant adenoviral vectors.";
RL   Patent number US6458586, 01-Oct-2002.
//
RX   PubMed=10516020; DOI=10.1128/JVI.73.11.9137-9144.1999;
RA   Reddy P.S., Idamakanti N., Chen Y., Whale T., Babiuk L.A., Mehtali M.,
RA   Tikoo S.K.;
RT   "Replication-defective bovine adenovirus type 3 as an expression
RT   vector.";
RL   J. Virol. 73:9137-9144(1999).
//